tiprankstipranks
Trending News
More News >
Nascent Pharma Holdings (NASC)
OTHER OTC:NASC
US Market

Nascent Pharma Holdings (NASC) Income Statement

Compare
28 Followers

Nascent Pharma Holdings Income Statement

Last quarter (Q3 2024), Nascent Pharma Holdings's total revenue was $15.27K, a decrease of -96.36% from the same quarter last year. In Q3, Nascent Pharma Holdings's net income was $-3.26M. See Nascent Pharma Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 2.16M$ 6.69M$ 4.60M$ 1.71M
Gross Profit
$ -742.32K$ 358.70K$ 2.61M$ 2.99M$ 1.43M
Operating Expenses
$ 4.02M$ 7.85M$ 16.78M$ 13.26M$ 8.97M
Depreciation and Amortization
$ 343.61K$ 1.40M$ 1.43M$ 542.35K$ 783.30K
EBITDA
$ -7.65M$ -5.82M$ -12.59M$ -9.52M$ -7.16M
Operating Income
$ -4.76M$ -7.49M$ -14.17M$ -10.27M$ -7.54M
Other Income/Expenses
$ -5.02M$ -2.24M$ -755.24K$ -1.90M$ -1.34M
Pretax Income
$ -9.78M$ -9.73M$ -14.92M$ -12.17M$ -8.88M
Net Income
$ -10.20M$ -9.74M$ -14.92M$ -12.17M$ -8.88M
Per Share Metrics
Basic EPS
$ -0.17$ -0.77$ -4.18$ -9.06$ -37.68
Diluted EPS
$ -0.17$ -0.77$ -4.18$ -9.06$ -37.68
Weighted Average Shares Outstanding
58.37M 12.59M 3.57M 1.34M 235.65K
Weighted Average Shares Outstanding (Diluted)
58.37M 12.59M 3.57M 1.34M 235.65K
Currency in USD

Nascent Pharma Holdings Earnings and Revenue History